https://scholars.lib.ntu.edu.tw/handle/123456789/532326
標題: | Hypertensive kidney disease | 作者: | Tsai I.-C. TUN-JUN TSAI |
公開日期: | 2009 | 卷: | 20 | 期: | 3 | 起(迄)頁: | 232-237 | 來源出版物: | Journal of Internal Medicine of Taiwan | 摘要: | Hypertensive kidney disease is one of the most common cause of end stage renal disease. Hypertension is also the most common complication of chronic kidney disease. Chronic hypertension makes the vessels of kidney become sclerotic and further deteriorate renal function. Factors that correlate with the progression of hypertensive kidney disease include blood pressure control, the severity of proteinuria, renal function, hyperlipidemia, races and genes, etc. The most effective medications for hypertensive kidney disease are angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. However, physicians should monitor renal function and serum potassium cautiously to decrease the risk of complications. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-67749113461&partnerID=40&md5=49849484bf9ce2f087ebb6d4ec17150e https://scholars.lib.ntu.edu.tw/handle/123456789/532326 |
ISSN: | 1016-7390 | SDG/關鍵字: | aldosterone antagonist; amlodipine; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; hydralazine; loop diuretic agent; losartan; metoprolol; potassium; ramipril; article; blood pressure regulation; chronic disease; chronic kidney disease; deterioration; disease severity; heredity; human; hyperlipidemia; kidney blood vessel; kidney failure; kidney function; kidney ischemia; nephrosclerosis; patient monitoring; potassium blood level; proteinuria; renin angiotensin aldosterone system; renovascular hypertension; risk reduction; sclerosis |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。